Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Regulatory status:
In the context of Cisplatin + Pemetrexed & Non-small-cell lung cancer (NSCLC) (Non-squamous Cell Carcinoma), Cisplatin + pemetrexed is an established doublet chemotherapy regimen, approved by the FDA and EMA, for Non-small-cell lung cancer (NSCLC) (Non-squamous Cell Carcinoma) used both in advanced/metastatic and postoperative adjuvant settings as a first-line treatment, with efficacy similar to other platinum-based combinations but a distinctive safety profile favoring certain patient populations (1, 2, 3).
####…